申请人:Sumitomo Pharmaceuticals Company, Limited
公开号:US04745117A1
公开(公告)日:1988-05-17
A compound of the formula: ##STR1## wherein A is a carbonyl group or a sulfonyl group; B is either one of the formulas: ##STR2## (in which E is a methylene group, an ethylene group or an oxygen atom and a full line accompanying a broken line ( ) indicates a single bond or a double bond), ##STR3## (in which F is a methylene group or an ethylene group and a full line accompanying a broken line ( ) is as defined above) and ##STR4## (in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are each a hydrogen atom or a methyl group) when A represents a carbonyl group, or B is a 1,2-phenylene group when A represents a sulfonyl group; D is an ethylene group, an ethenylene group or an ethynylene group, of which one or more may be optionally substituted with hydroxyl; and n is an integer of 0, 1 or 2, or its acid addition salt. These compounds are useful for the treatment or psychosis.
一种化合物的公式:##STR1##
其中A是一个羰基团或磺酰基团; B是以下公式之一:##STR2##
(其中E是亚甲基,乙烯基或氧原子,伴随着中断线()的实线表示单键或双键),
##STR3##
(其中F是亚甲基或乙烯基,伴随着中断线()的实线与上述定义相同)和
##STR4##
(其中R.sup.1,R.sup.2,R.sup.3,R.sup.4,R.sup.5和R.sup.6分别是氢原子或甲基),当A表示羰基团时,B为1,2-苯基基团,当A表示磺酰基团时; D是乙烯基,乙烯基或乙炔基,其中一个或多个可以选择性地被氢氧化; n是0,1或2的整数,或其酸加成盐。这些化合物对于治疗精神病非常有用。